Clinical Trials Browser

Phase 2 × Interventional × Trace amine-associated receptor 1 × Clear all

NCT06829355 2025-02-17

THYMI

Phase 2 Recruiting

MCRC

NCT02906150 2016-09-19

Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung